News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dendreon Corporation (DNDN) Shares Halted Ahead of FDA Meeting


3/29/2007 12:11:01 PM

SAN FRANCISCO (MarketWatch) -- Shares of Dendreon Corp. were halted before the start of trading Thursday, ahead of a Food and Drug Administration advisory committee meeting to evaluate Provenge, the company's experimental prostate-cancer drug.

>>> Discuss This Story


Read at Market Watch


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES